[{"id":"7ca1a5b6-b5e3-4622-8a4f-a462e3ff4894","acronym":"","url":"https://clinicaltrials.gov/study/NCT05498519","created_at":"2022-08-13T17:57:29.618Z","updated_at":"2024-07-02T16:35:48.307Z","phase":"Phase 1","brief_title":"A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor","source_id_and_acronym":"NCT05498519","lead_sponsor":"Shouyao Holdings (Beijing) Co. LTD","biomarkers":" FGF19","pipe":"","alterations":" ","tags":["FGF19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SY-4798"],"overall_status":"Recruiting","enrollment":" Enrollment 80","initiation":"Initiation: 04/15/2021","start_date":" 04/15/2021","primary_txt":" Primary completion: 04/15/2024","primary_completion_date":" 04/15/2024","study_txt":" Completion: 04/15/2024","study_completion_date":" 04/15/2024","last_update_posted":"2023-05-11"}]